Table 1.
Overview of samples used in this study.
| HCV Status | Origin | n Samples | n Female | n Male | n Samples w/o Data | Mean Age Female | Mean Age Male |
|---|---|---|---|---|---|---|---|
| Acute | Egypt | 166 | 61 | 103 | 2 | 35.0 ± 10.2 | 35.1 ± 10.6 |
| Chronic | Egypt | 33 | 18 | 15 | - | 47.8 ± 8.6 | 38.5 ± 12.1 |
| Chronic | France | 108 | 46 | 61 | 1 | 59.5 ± 10.1 | 55.1 ± 9.0 |
| Negative | Egypt | 26 | n/a | n/a | 26 | n/a | n/a |
| Negative | France | 61 | 25 | 36 | - | 35.7 ± 11.0 | 38.8 ± 14.2 |
| Negative | USA | 30 | 15 | 15 | - | 37.7 ± 13.7 | 45.5 ± 13.8 |
| Time ourse * (Acute/Chronic) | Egypt | 107 (26 patients) | 10 | 16 | - | 34.4 ± 9.5 | 35.8 ± 11.7 |
* ANRS study. w/o: Without; n/a: Not available.